Navigation Links
Advance in Bowel Cancer Test Research
Date:6/3/2009

SYDNEY, June 3 /PRNewswire/ -- Australian researchers have developed gene expression biomarkers which can accurately discriminate pre-cancerous and cancerous colorectal growths from non-cancerous controls.

Being presented today at the Digestive Disease Week conference in Chicago, the preliminary findings are the result of a collaborative study - involving CSIRO, Flinders University and Australian healthcare company, Clinical Genomics Pty Ltd - designed to develop an improved screening/diagnostic test for detecting bowel cancer and significant pre-cancer lesions.

"If we can now show that the levels of these biomarkers in blood or stool also correlate strongly with disease state in a large group of patients with cancer or pre-cancer lesions (ie adenomatous polyps) we may have the basis for a very important new diagnostic weapon in the fight against bowel cancer," says CSIRO's Preventative Health National Research Flagship Theme Leader in Colorectal Cancer and Gut Health, Dr Trevor Lockett.

According to Professor Graeme Young from Flinders University's Centre for Cancer Prevention and Control, regular screening for bowel cancer in people aged 50 years and over is a powerful tool for reducing the impact of the disease in Australia.

"If we can develop a screening test that can point to the presence of clinically important pre-cancerous adenomas which are then removed during follow-up colonoscopy, we will actually be able to prevent the occurrence of bowel cancer in some cases," Professor Young says.

The CEO of Clinical Genomics Pty Ltd, Lawrence La Pointe, says if a more robust screening test for bowel cancer and especially pre-cancer lesions emerges, the research team will have achieved a major advance likely to further improve screening outcomes and more precisely identify those people most likely to benefit from colonoscopic investigation.

Digestive Diseases
'/>"/>

SOURCE Clinical Genomics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
6. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
7. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
10. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
11. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Report Details  New study shows ... What does the future hold for top companies ... new report shows you potential revenues to 2025, assessing ... 242-page report provides 185 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
(Date:3/27/2015)... , March 27, 2015   Hospira, ... leader in biosimilars and the world,s leading provider ... studies that support an evaluation of biosimilarity of ... Food and Drug Administration (FDA) conditionally approved name ... EPOGEN™ (epoetin alfa). These study data were presented ...
(Date:3/27/2015)... 27, 2015 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution ... radiotherapy and diagnostic imaging centers in ... a purchase agreement under which Concord Medical Services ... the Company, agreed to acquire the Fortis Surgical ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3
... ClinStar, LLC, an established CRO providing clinical research ... Europe to the pharmaceutical and biotechnology industry, announced today ... East Coast of the United States. ... US location to its headquarters in San Francisco, CA, ...
... Oncology treatments are not what they were a decade ... cancer cell are being added to or replacing once ...  Medco Health Solutions, Inc. (NYSE: MHS ) ... that include treatment pathways decision support with embedded pharmacogenomic ...
Cached Medicine Technology:ClinStar, LLC Establishes New Office on the US East Coast 2Cancer Game Changers: Genomics, Smarter Medicine, Care Coordination Comprise Medco's Advanced Oncology Solutions™ 2Cancer Game Changers: Genomics, Smarter Medicine, Care Coordination Comprise Medco's Advanced Oncology Solutions™ 3Cancer Game Changers: Genomics, Smarter Medicine, Care Coordination Comprise Medco's Advanced Oncology Solutions™ 4Cancer Game Changers: Genomics, Smarter Medicine, Care Coordination Comprise Medco's Advanced Oncology Solutions™ 5
(Date:3/28/2015)... Portland, OR (PRWEB) March 28, 2015 ... in the media regarding recent changes and proposals around ... TV , current and former collegiate student-athletes across a ... experiences and reflect on common challenges. The special panel ... the country in sports ranging from football, track and ...
(Date:3/28/2015)... Designers and Professionals of FCPX ... 5K from Pixel Film Studios. , “Scratches 5K allows ... inside Final Cut Pro X” Said Christina Austin, CEO ... is an effective tool for any FCPX editor.” , ... intuitive grunge overlays. Simply drag title layers into the ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 LTW Cyber ... agreed to collaborate for the purpose of addressing the ... venture will pursue its own opportunities to grow while ... part of LTW Cyber. , Ventures in LTW Cyber ... and complemented by offerings identifying vulnerabilities and analyzing open ...
(Date:3/27/2015)... 2015 Florida Hospital is excited to continue ... exclusive health care provider for the 2015 and 2016 season. ... medical care and an athletic trainer for the team throughout ... its season against the Cleveland Gladiators at Amalie Arena; the ... extremely important to us as it gives us the opportunity, ...
(Date:3/27/2015)... NY (PRWEB) March 27, 2015 ... more plastic surgery patients travel to the Dominican Republic ... The plastic surgery clinic is turning the medical tourism ... cosmetic surgery patients — with trustworthy services becoming the ... when selecting a plastic surgeon. Patients are not only ...
Breaking Medicine News(10 mins):Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 2Health News:Florida Hospital Is Kicking off the 2015 Season as the Exclusive Health Care Provider for the Tampa Bay Storm 3Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3
... HealthDay Reporter , TUESDAY, Aug. 16 (HealthDay News) ... be given radioactive iodine unnecessarily, while others with more ... new study suggests. More than 44,000 people are ... according to the study. When caught early, it is ...
... By Alan Mozes HealthDay Reporter , ... patients afflicted with a particularly severe, crippling form of ... ineffective, a recently approved alternative appears to afford relief. ... Krystexxa) has no effect on most severe gout patients, ...
... current expenses and largely unable to meet essential future ones, ... new poll from The SCAN Foundation and the UCLA Center ... its second year, sought to better understand health and long-term ... crisis and the rising number of Californians older than 60, ...
... scholar Cynthia Wu has spent years studying Chang and ... "human marvels." "The Bunker twins," she says, "have served ... paradox that while ,individualism, is what makes Americans stand ... assistant professor of American studies at the University at ...
... There was a dramatic increase in the number of children,s flu-related ... federal agency says. Over that time, flu rose from 65th ... and younger go to the hospital, according to a report from ... also found that skin infections rose from 13th to 7th in ...
... Medical Sciences of the National Institutes of Health recently ... cell biology in Wayne State University,s College of Liberal ... alteration of chromatin regulates cellular division and growth. The ... treatments currently undergoing clinical trials. Chromatin is a ...
Cached Medicine News:Health News:Some Thyroid Cancer Patients May Get Radioactive Iodine Unnecessarily 2Health News:Some Thyroid Cancer Patients May Get Radioactive Iodine Unnecessarily 3Health News:Some Thyroid Cancer Patients May Get Radioactive Iodine Unnecessarily 4Health News:New Drug May Relieve Severe, Tough-to-Treat Gout 2Health News:New Drug May Relieve Severe, Tough-to-Treat Gout 3Health News:New Drug May Relieve Severe, Tough-to-Treat Gout 4Health News:Poll finds two-thirds of California voters unprepared for costs of growing older 2Health News:Poll finds two-thirds of California voters unprepared for costs of growing older 3Health News:Poll finds two-thirds of California voters unprepared for costs of growing older 4Health News:Research on famous Siamese twins demonstrates how the paradox of American identity played out in the bodies of Chang and Eng 2Health News:Research on famous Siamese twins demonstrates how the paradox of American identity played out in the bodies of Chang and Eng 3Health News:NIH awards WSU researcher $1.39M to study chromatin's role in cell division 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: